Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

184

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02CC05	ALMOVITAE	G	Almotriptan - 12.5mg	12.5mg	Tablet, film coated	1,148,985 L.L
N05AX12	ATYPRAL	G	Aripiprazole - 15mg	15mg	Tablet	712,237 L.L
N07CA03	ZINASEN	G	Flunarizine (HCl) - 10mg	10mg	Tablet	599,354 L.L
R05CB06	MUKORAL	G	Ambroxol - 30mg	30mg	Tablet	201,576 L.L
S02CA06	POLYDEXA	G	Dexamethasone sodium metasulfobenzoate - 1.000.000IU/100ml, Polymyxin B sulfate - 100mg/100ml, Neomycin sulfate - 650.000IU/100ml		Drops solution	208,296 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
C09AA05	TRILTEC	G	Ramipril - 5mg	5mg	Capsule	447,948 L.L
C10AA03	APO-PRAVASTATIN	G	Pravastatin Sodium - 20mg	20mg	Tablet	775,397 L.L
D06BB03	CYCLOVEX	G	Aciclovir - 50mg/g	50mg/g	Cream	345,560 L.L
J01CA01	ANTALPEN	G	Ampicillin (trihydrate) - 250mg	250mg	Capsule	218,854 L.L
J01EE01	CO-TRIMOXAZOLE	G	Trimethoprim - 160mg, Sulfamethoxazole - 800mg		Tablet	7,529,090 L.L
J05AF10	ENTECAVIR BIOGARAN	G	Entecavir - 0.5mg	0.5mg	Tablet, coated	19,080,319 L.L
L04AX07	MAROVAREX	G	Dimethyl Fumarate - 240mg		Capsule, hard, gastro-resistant	60,848,734 L.L
M05BA07	RISEDRONATE ARROW	G	Risedronate sodium - 35mg	35mg	Tablet, film coated	671,921 L.L
N05AX12	JOSWE ARIPAL 15	G	Aripiprazole - 15mg	15mg	Tablet	2,413,541 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	2,303,346 L.L
S02CA06	AURICULARUM	G	Dexamethasone (sodium phosphate) - 10mg, Nystatin - 1,000,000IU, Oxytetracycline HCl - 90,000IU, Polymyxin B sulfate - 100,000IU		Powder for suspension + solvent	755,239 L.L
A06AA01	HUILE DE PARAFFINE	G	Liquid paraffin -		Liquid	207,336 L.L
B01AE07	DAXATRAN	G	Dabigatran etexilate (mesilate) - 150mg	150mg	Capsule, hard	2,576,338 L.L
B05BC01	OSMITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	579,064 L.L
C01EB17	BRADIREM	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,134,203 L.L
C10AA03	PRAVASTATINE ARROW	G	Pravastatin - 20mg	20mg	Tablet, breakable	526,786 L.L
J01CA01	ANTALPEN	G	Ampicillin (trihydrate) - 500mg	500mg	Capsule	285,407 L.L
J01EE01	CO-TRIMOXAZOLE	G	Trimethoprim - 160mg, Sulfamethoxazole - 800mg		Tablet	183,019 L.L
J05AF10	ENTRILIV	G	Entecavir - 0.5mg	0.5mg	Tablet, film coated	19,165,898 L.L
L01DB03	EPIRUBICINE VIATRIS 2MG/ML	G	Epirubicin HCl - 10mg/5ml	10mg/5ml	Injectable solution	855,212 L.L
L04AX07	TECFEO 240	G	Dimethyl Fumarate - 240mg	240mg	Capsule, delayed release	67,784,092 L.L
M05BA07	APO-RISEDRONATE	G	Risedronate sodium - 150mg	150mg	Tablet	1,034,759 L.L
N05AX12	PIRIFY	G	Aripiprazole - 15mg	15mg	Tablet	795,555 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	3,886,393 L.L

...

184